AGS-v PLUS

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGS-v PLUS, covering 2022-04-28 to 2022-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine [Phase 1]

See pricing